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Abstract 
This dataset contains anonymised human 
lung computed tomography (CT) scans with 
COVID-19 related findings, as well as without 
such findings. A small subset of studies has 
been annotated with binary pixel masks 
depicting regions of interests (ground-glass 
opacifications and consolidations). CT scans 
were obtained between 1st of March, 2020 and 
25th of April, 2020, and provided by municipal 
hospitals in Moscow, Russia. Permanent link: 
https://mosmed.ai/datasets/covid19_1110. This 
dataset is licensed under a Creative Commons 
Attribution-NonCommercial-NoDerivs 3.0 
Unported (CC BY-NC-ND 3.0) License. 
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Background 
During the COVID-19 pandemic, most 
countries faced a tremendous increase in the 
healthcare burden. This situation calls for the 
most careful use of financial and human 
resources than ever before. Unfortunately, the 
preventive measures put in place in medical 
facilities are not always enough to avoid deaths 
of medical workers. The loss of trained 
specialists in emergency care, radiology, etc., is 
especially concerning. Computed tomography 
is considered a key tool to diagnose and 
evaluate the progression of COVID-19. The CT 
studies are performed in the outpatient setting 
and target patients with acute respiratory 
symptoms, and those with established diagnosis 
and mild disease progression who are able to 
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recover in their homes (under supervision via 
telemedicine). Inpatient facilities use CT for 
initial and differential diagnostic assessment, 
evaluation of disease progression, and 
determining, whether the patient should be 
admitted to the intensive care unit or discharged 
[1,3,4]. 
The ever-increasing use of CT translates 
to an immense burden on the health system. For 
example, in Moscow, the chain of municipal 
outpatient CT centers perform about 90 studies 
per 1 CT scanner per day (the record holder 
scanner performed 163 studies during one day). 
To standardize and streamline clinical 
decision-making the experts developed a 
classification model that grades the severity of 
lung tissue abnormalities observed on CT 
images along with other symptoms (see Table). 
Increased burnout and high risk of 
occupational death among healthcare workers 
call for automation of the reading process, 
which will improve productivity and minimize 
errors [8]. Preliminary figures indicate the AI 
algorithms have sufficient accuracy for the 
diagnostic evaluation of COVID-19 
(responsiveness – 90%, specificity – 96%, 
AUC – 0.96, overall accuracy 76.37-98.26) 
[6,9]. 
Dataset 
Data were obtained between 1st of 
March, 2020 and 25th of April, 2020, and 
provided by municipal hospitals in Moscow, 
Russia. This dataset contains anonymised 
human lung computed tomography (CT) scans 
with COVID-19 related findings (CT1-CT4), as 
well as without such findings (CT0) (fig.).  
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There are 1110 studies in dataset. Population: 
1110 persons, males – 42%, females – 56%, 
other/unknown – 2%; age from 18 to 97 years, 
median – 47 years. As a first step, all studies 
(n=1110) were distributed into 5 categories 
according to classification (table).  Number of 
cases by category: CT-0 – 254 (22,8%), CT-1 – 
684 (61,6%), CT-2 –  125 (11,3%), CT-3 –  45 
(4,1%), CT-4 –  2 (0,2%). Secondly, every 
study has been saved in NifTI format and 
archived into Gzip archive. During this process 
only every 10-th image (Instance) was 
preserved in the final study file.  
 
 
Table. Classification of the severity of lung tissue abnormalities with COVID-19 and routing rules 
Severity CT Clinical Data Decision 
Zero 
CT-0 
Not consistent with 
pneumonia (including 
COVID-19). 
 –  Inform the attending physician. Refer to a 
specialist. 
Mild 
CT-1 
Ground glass opacities. 
Pulmonary parenchymal 
involvement =<25% OR 
absence 
CT signs in typical clinical 
manifestations and relevant 
epidemiological history. 
A. t0 <38.00С 
B. RR <20/min 
C. SpO2 >95%  
Follow-up at home using telemedicine 
technologies (mandatory 
telemonitoring) 
Moderate 
CT-2 
Ground glass opacities. 
Pulmonary parenchymal 
involvement 25-50%. 
A. t0 >38.50С 
B. RR 20-30/min 
C. SpO2 95% 
Follow-up at home by a primary care 
physician 
Severe 
CT-3 
Ground glass opacities. 
Pulmonary consolidation. 
Pulmonary parenchymal 
involvement 50-75%. 
Lung involvement increased 
in 24–48 hours by 50% in 
respiratory impairment per 
follow-up studies. 
One or more signs on the 
background of fever:  
A. t0 >38,50С 
B. RR ≥30/min 
C. SpO2 ≤95% 
D. Partial pressure of 
oxygen (PaO2)/ Fraction 
of inspired oxygen 
(FiO2) ≤300 mmHg 
(1 mmHg=0,133 kPa) 
Immediate admission to a COVID-
specialized hospital. 
In a hospital setting: immediate transfer to 
the intensive care and resuscitation unit. 
Emergency computed tomography (if not 
done before). 
Critical  
CT-4 
Diffuse ground glass opacities 
with consolidations and 
reticular changes. 
Hydrothorax (bilateral, more 
on the left). 
Pulmonary parenchymal 
involvement >=75%. 
Signs of shock, multiple 
organ failure, respiratory 
failure. 
Emergency medical care. 
Immediate admission to a specialized 
hospital for patients diagnosed with 
COVID-19. 
In a hospital setting: immediate transfer to 
the intensive care and resuscitation unit. 
Emergency computed tomography (if not 
done before and when patient status allows 
for it). 
 
A small subset of studies (n=50) has been 
annotated by the experts of Research and 
Practical Clinical Center for Diagnostics and 
Telemedicine Technologies of the Moscow 
Health Care Department. During the annotation 
for every given image ground-glass 
opacifications and regions of consolidation 
were selected as positive (white) pixels on the 
corresponding binary pixel mask. The resulting 
masks have been saved in NIfTI format and 
then transformed into Gzip archives. The 
MedSeg® web-based annotation software has 
been used for creating binary masks (© 2020 
Artificial Intelligence AS). 
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Fig. Examples of images: a – CT-0, b – CT-1 (overlay: binary mask), c – CT-2, d – CT-3, e – CT-4 
 
Value 
The dataset is intended for education, 
calibration, and independent assessment of the 
AI (computer vision) algorithms [7]. 
To help combating COVID-19 the AI 
(computer vision) algorithms will allow: 
1. Triaging patients in outpatient facilities 
to secure rapid and consistent routing (incl. 
based on the CT0-4 criteria) 
2. Prioritizing studies that contain signs of 
COVID-19 in the worklist 
3. Performing a rapid and high-quality 
assessment of abnormal changes by comparing 
several studies 
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4. Minimizing the risks of errors and 
missed abnormalities. 
At the moment, there is a wide range of 
publicly available COVID-19 datasets [2,5]. 
However, this should not be viewed as an 
obstacle for the following reasons: 
1. Development of algorithms requires 
large volumes of high-quality clinical data that 
is representative of real-world patient 
populations 
2. The algorithms must be verified with 
new data, i.e. new datasets that were not used 
during the learning and calibration phases. The 
more data are available in the open sources, the 
better for the developers 
3.  The available datasets are relatively 
small and rarely present additional information, 
such as tags and/or binary masks for the regions 
of interest (ROI). 
Permanent link: 
https://mosmed.ai/datasets/covid19_1110. This 
dataset is licensed under a Creative Commons 
Attribution-NonCommercial-NoDerivs 3.0 
Unported (CC BY-NC-ND 3.0) License. 
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